Argenx Se (ARGX) Long-Term Deferred Tax (2016 - 2025)
Argenx Se (ARGX) posted Long-Term Deferred Tax of $1.3 billion for Q4 2025, down 99.86% on a QoQ basis from $899.6 billion in Q2 2025, and up 40.2% year-over-year from $924.3 million in Q4 2024.
Argenx Se (ARGX) Long-Term Deferred Tax (2016 - 2025) Analysis & Trends
Argenx Se's Long-Term Deferred Tax history runs 10 years deep, the most recent figure standing at $1.3 billion for Q4 2025.
- Quarterly Long-Term Deferred Tax rose 40.2% year-over-year to $1.3 billion in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $1.3 billion (up 40.2% YoY) and the FY2025 annual result came in at $1.3 billion, up 40.2% from the prior year.
- Long-Term Deferred Tax was $1.3 billion for Q4 2025 at Argenx Se, down from $899.6 billion in the prior quarter.
- Across five years, Long-Term Deferred Tax topped out at $899.6 billion in Q2 2025 and bottomed at $16.3 million in Q2 2021.
- A 5-year average of $90.2 billion and a median of $118.0 million in 2023 frame the typical range for Long-Term Deferred Tax.
- Annual changes were most pronounced in 2023 — Long-Term Deferred Tax advanced 22.71% — and 2025, when it jumped 515062.12%.
- Argenx Se's Long-Term Deferred Tax stood at $32.2 million in 2021, then jumped by 146.1% to $79.2 million in 2022, then advanced by 22.71% to $97.2 million in 2023, then surged by 850.82% to $924.3 million in 2024, then soared by 40.2% to $1.3 billion in 2025.
- Business Quant data shows ARGX's Long-Term Deferred Tax at $1.3 billion in Q4 2025, $899.6 billion in Q2 2025, and $924.3 million in Q4 2024.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - |
| 10 | Alnylam Pharmaceuticals | 36.08 Bn | 33.07 Bn | 959.66 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 1.30 Bn |
| Jun 30, 2025 | 899.61 Bn |
| Dec 31, 2024 | 924.30 Mn |
| Jun 30, 2024 | 174.63 Mn |
| Dec 31, 2023 | 97.21 Mn |
| Jun 30, 2023 | 138.77 Mn |
| Dec 31, 2022 | 79.22 Mn |
| Jun 30, 2022 | 54.27 Mn |
| Dec 31, 2021 | 32.19 Mn |
| Jun 30, 2021 | 16.25 Mn |
| Dec 31, 2020 | 14.61 Mn |
| Dec 31, 2019 | 44.28 Mn |
| Dec 31, 2018 | 33.44 Mn |
| Dec 31, 2017 | 33.44 Mn |
| Dec 31, 2016 | 7.13 Mn |